TransPerfect, a global leader in language and technology solutions, has made a significant move by acquiring Synterex, a clinical and regulatory writing consultancy, on August 20, 2026. This acquisition underscores TransPerfect's commitment to enhancing its medical writing capabilities and broadening its portfolio within life sciences. The integration of Synterex’s 60-person team, which specializes in clinical and regulatory documentation, introduces a robust AI-assisted content workflow to the company's offerings through AgileWriter.ai. This software enhancement is expected to streamline the content development process in the medical writing sector.

Phil Shawe, President and Co-CEO of TransPerfect, emphasized the strategic nature of this acquisition. “We’ve made it a priority to expand our existing medical writing offering,” he stated, indicating that the synergy between TransPerfect and Synterex is geared towards fostering more efficient and innovative approaches to medical content creation. This initiative is aligned with TransPerfect's broader strategy, as evidenced by its active pursuit of mergers and acquisitions in the life sciences domain. In 2025 alone, the company executed 10 strategic acquisitions, boosting its operational reach and service capabilities. The addition of Synterex reflects a natural progression in enhancing its AI competencies—highlighting the company's dedication to leveraging technology for faster and more accurate service delivery.

The financial specifics of the Synterex acquisition remain undisclosed, but it is part of a clear pattern of aggressive expansion that TransPerfect has consistently pursued. In 2025, the company reported a 7% increase in billed revenue, amounting to USD 1.32 billion. The recent acquisitions of the German post-production company Omnimago in February 2026 and Rome-based Studio Emme in April 2026 illustrate TransPerfect's diversified approach to growth, both geographically and in terms of service offerings. As outlined by Slator, this acquisition spree indicates a deliberate strategy to fortify its presence in key sectors.

This deal is anticipated to enhance TransPerfect’s capabilities, enabling teams to "ship faster and iterate on ideas" with greater efficiency than would have been conceivable just months ago, a sentiment expressed by Shawe. By integrating Synterex’s expertise and AgileWriter.ai technology, TransPerfect is setting a new industry standard for AI-assisted medical documentation, a step that not only positions the company advantageously in the competitive landscape but also promises to deliver amplified value to its clients in the healthcare and regulatory sectors.